148 related articles for article (PubMed ID: 21291379)
1. Amino acid-substituted gemini surfactant-based nanoparticles as safe and versatile gene delivery agents.
Singh J; Yang P; Michel D; Verrall RE; Foldvari M; Badea I
Curr Drug Deliv; 2011 May; 8(3):299-306. PubMed ID: 21291379
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles.
Singh J; Michel D; Chitanda JM; Verrall RE; Badea I
J Nanobiotechnology; 2012 Feb; 10():7. PubMed ID: 22296763
[TBL] [Abstract][Full Text] [Related]
3. Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles.
Yang P; Singh J; Wettig S; Foldvari M; Verrall RE; Badea I
Eur J Pharm Biopharm; 2010 Aug; 75(3):311-20. PubMed ID: 20417276
[TBL] [Abstract][Full Text] [Related]
4. Development of amino acid substituted gemini surfactant-based mucoadhesive gene delivery systems for potential use as noninvasive vaginal genetic vaccination.
Singh J; Michel D; Getson HM; Chitanda JM; Verrall RE; Badea I
Nanomedicine (Lond); 2015 Feb; 10(3):405-17. PubMed ID: 25707975
[TBL] [Abstract][Full Text] [Related]
5. Cellular Uptake and Distribution of Gemini Surfactant Nanoparticles Used as Gene Delivery Agents.
Jin W; Al-Dulaymi M; Badea I; Leary SC; Rehman J; El-Aneed A
AAPS J; 2019 Aug; 21(5):98. PubMed ID: 31388860
[TBL] [Abstract][Full Text] [Related]
6. Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.
Narsineni L; Foldvari M
Pharm Res; 2020 Jul; 37(7):144. PubMed ID: 32666411
[TBL] [Abstract][Full Text] [Related]
7. Di-Peptide-Modified Gemini Surfactants as Gene Delivery Vectors: Exploring the Role of the Alkyl Tail in Their Physicochemical Behavior and Biological Activity.
Al-Dulaymi MA; Chitanda JM; Mohammed-Saeid W; Araghi HY; Verrall RE; Grochulski P; Badea I
AAPS J; 2016 Sep; 18(5):1168-1181. PubMed ID: 27184577
[TBL] [Abstract][Full Text] [Related]
8. New serine-derived gemini surfactants as gene delivery systems.
Cardoso AM; Morais CM; Cruz AR; Silva SG; do Vale ML; Marques EF; de Lima MC; Jurado AS
Eur J Pharm Biopharm; 2015 Jan; 89():347-56. PubMed ID: 25513958
[TBL] [Abstract][Full Text] [Related]
9. Molecular Engineering as an Approach To Modulate Gene Delivery Efficiency of Peptide-Modified Gemini Surfactants.
Al-Dulaymi M; Michel D; Chitanda JM; El-Aneed A; Verrall RE; Grochulski P; Badea I
Bioconjug Chem; 2018 Oct; 29(10):3293-3308. PubMed ID: 30169953
[TBL] [Abstract][Full Text] [Related]
10. Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles.
Wettig SD; Badea I; Donkuru M; Verrall RE; Foldvari M
J Gene Med; 2007 Aug; 9(8):649-58. PubMed ID: 17654656
[TBL] [Abstract][Full Text] [Related]
11. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
Mohammed-Saeid W; Michel D; El-Aneed A; Verrall RE; Low NH; Badea I
J Pharm Pharm Sci; 2012; 15(4):548-67. PubMed ID: 23106958
[TBL] [Abstract][Full Text] [Related]
12. Design and Evaluation of RGD-Modified Gemini Surfactant-Based Lipoplexes for Targeted Gene Therapy in Melanoma Model.
Mohammed-Saeid W; Chitanda J; Al-Dulaymi M; Verrall R; Badea I
Pharm Res; 2017 Sep; 34(9):1886-1896. PubMed ID: 28643235
[TBL] [Abstract][Full Text] [Related]
13. Gemini surfactant dimethylene-1,2-bis(tetradecyldimethylammonium bromide)-based gene vectors: a biophysical approach to transfection efficiency.
Cardoso AM; Faneca H; Almeida JA; Pais AA; Marques EF; de Lima MC; Jurado AS
Biochim Biophys Acta; 2011 Jan; 1808(1):341-51. PubMed ID: 20937247
[TBL] [Abstract][Full Text] [Related]
14. A flow cytometric approach to study the mechanism of gene delivery to cells by gemini-lipid nanoparticles: an implication for cell membrane nanoporation.
Gharagozloo M; Rafiee A; Chen DW; Foldvari M
J Nanobiotechnology; 2015 Sep; 13():62. PubMed ID: 26415935
[TBL] [Abstract][Full Text] [Related]
15. Tuning optimum transfection of gemini surfactant-phospholipid-DNA nanoparticles by validated theoretical modeling.
Taheri-Araghi S; Chen DW; Kohandel M; Sivaloganathan S; Foldvari M
Nanoscale; 2019 Jan; 11(3):1037-1046. PubMed ID: 30569915
[TBL] [Abstract][Full Text] [Related]
16. Transfection of plasmid DNA by nanocarriers containing a gemini cationic lipid with an aromatic spacer or its monomeric counterpart.
Martínez-Negro M; Barrán-Berdón AL; Aicart-Ramos C; Moyá ML; de Ilarduya CT; Aicart E; Junquera E
Colloids Surf B Biointerfaces; 2018 Jan; 161():519-527. PubMed ID: 29128838
[TBL] [Abstract][Full Text] [Related]
17. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.
Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E
Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552
[TBL] [Abstract][Full Text] [Related]
18. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I.
Ahmed T; Kamel AO; Wettig SD
Nanomedicine (Lond); 2016 Feb; 11(3):289-306. PubMed ID: 26785905
[TBL] [Abstract][Full Text] [Related]
19. Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated
Massa M; Rivara M; Donofrio G; Cristofolini L; Peracchia E; Compari C; Bacciottini F; Orsi D; Franceschi V; Fisicaro E
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328483
[TBL] [Abstract][Full Text] [Related]
20. Gemini surfactant-based nanoparticles T-box1 gene delivery as a novel approach to promote epithelial stem cells differentiation and dental enamel formation.
Mohabatpour F; Al-Dulaymi M; Lobanova L; Scutchings B; Papagerakis S; Badea I; Chen X; Papagerakis P
Biomater Adv; 2022 Jun; 137():212844. PubMed ID: 35929273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]